Vitamin Shoppe, Inc (NYSE:VSI) shares dropped 36.5% during mid-day trading on Wednesday following a weaker than expected earnings announcement. The stock traded as low as $6.05 and last traded at $6.10, with a volume of 5,148,727 shares trading hands. The stock had previously closed at $9.60.

The specialty retailer reported $0.23 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.39 by $0.16. Vitamin Shoppe had a net margin of 1.43% and a return on equity of 9.35%. The business had revenue of $304.84 million for the quarter, compared to analyst estimates of $314.74 million. During the same quarter in the previous year, the company posted $0.55 earnings per share. The business’s revenue for the quarter was down 8.4% on a year-over-year basis.

A number of analysts have recently commented on the company. BidaskClub cut Vitamin Shoppe from a “hold” rating to a “sell” rating in a research note on Thursday, July 27th. Zacks Investment Research raised Vitamin Shoppe from a “strong sell” rating to a “hold” rating in a research note on Tuesday, July 18th. ValuEngine cut Vitamin Shoppe from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Barclays PLC reaffirmed an “equal weight” rating and issued a $13.00 price target (down from $24.00) on shares of Vitamin Shoppe in a research note on Sunday, May 14th. Finally, Gabelli cut Vitamin Shoppe from a “buy” rating to a “hold” rating in a research note on Thursday, May 11th. Two investment analysts have rated the stock with a sell rating and seven have issued a hold rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $21.50.

Several hedge funds have recently made changes to their positions in the stock. Los Angeles Capital Management & Equity Research Inc. bought a new stake in shares of Vitamin Shoppe during the second quarter worth approximately $877,000. Airain ltd bought a new stake in shares of Vitamin Shoppe during the second quarter worth approximately $259,000. BNP Paribas Arbitrage SA boosted its stake in shares of Vitamin Shoppe by 2.1% in the second quarter. BNP Paribas Arbitrage SA now owns 9,242 shares of the specialty retailer’s stock worth $108,000 after buying an additional 192 shares during the period. Legal & General Group Plc boosted its stake in shares of Vitamin Shoppe by 9.3% in the second quarter. Legal & General Group Plc now owns 44,555 shares of the specialty retailer’s stock worth $518,000 after buying an additional 3,789 shares during the period. Finally, Arizona State Retirement System boosted its stake in shares of Vitamin Shoppe by 0.8% in the second quarter. Arizona State Retirement System now owns 12,460 shares of the specialty retailer’s stock worth $145,000 after buying an additional 100 shares during the period.

The company has a market capitalization of $141.29 million, a P/E ratio of 7.85 and a beta of 0.68. The company’s 50 day moving average price is $10.92 and its 200 day moving average price is $16.44.

ILLEGAL ACTIVITY NOTICE: “Vitamin Shoppe, Inc (NYSE:VSI) Stock Price Down 36.5% Following Weak Earnings” was first published by Watch List News and is the sole property of of Watch List News. If you are accessing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright and trademark law. The original version of this piece of content can be viewed at https://www.watchlistnews.com/vitamin-shoppe-inc-nysevsi-stock-price-down-36-5-following-weak-earnings/1466301.html.

About Vitamin Shoppe

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.